Mesa Laboratories, Inc.
Health
Performance
7.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

Mesa Laboratories, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

27.01.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
11.11.2025
Off life support. Still risky, but slightly less scary.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

Mesa Laboratories, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Mesa Laboratories, Inc. do? Business model and key facts

Get the full picture of Mesa Laboratories, Inc.: what it builds, where it operates, and how it makes money.

Mesa Laboratories, Inc. Profile

Sector: Technology

Industry: Hardware, Equipment & Parts

Employees (FY): 736

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

shop
Company facts
Gary Owens
CEO
736
Employees worldwide
shop
Performance
-41.42%
Last 12 months
-72.3%
Last 5 years
shop
Growth
$240,98M
Revenue year
$-1.974.000
Net income
shop
Valuation
$450,51M
Market Cap
-326.35
Price/Earnings Ratio

Stocks related to Mesa Laboratories, Inc.

Selected based on industry alignment and relative market positioning.

VPG
Vishay Precision Group, Inc.
44.98
+4.73%
7.2
Sell
Buy
Vishay Precision Group, Inc.
LYTS
LSI Industries Inc.
22.14
+0.73%
5.9
Sell
Buy
LSI Industries Inc.
FARO
FARO Technologies, Inc.
43.99
+0.48%
6.2
Sell
Buy
FARO Technologies, Inc.
MEI
Methode Electronics, Inc.
8.10
+6.44%
7.5
Sell
Buy
Methode Electronics, Inc.
RELL
Richardson Electronics, Ltd.
12.24
+10.37%
6.5
Sell
Buy
Richardson Electronics, Ltd.

Events and news impacting Mesa Laboratories, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Mesa Laboratories, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.